Core Insights - Conavi Medical Corp. has entered into an agreement with the Province of Ontario under the Life Sciences Scale-Up Fund (LSSUF) to support the commercial launch of its next-generation Novasight Hybrid™ system [1][2][3] Group 1: Financial Support and Project Details - The LSSUF will provide Conavi with up to $2.5 million CAD, covering up to one-third of eligible project costs related to the Novasight Hybrid™ system [2] - The funding is contingent upon meeting certain requirements as part of the project [2] Group 2: Product and Technology - The Novasight Hybrid™ system integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single device, offering comprehensive imaging of coronary arteries [3][4] - This dual-modality approach aims to enhance the precision of diagnosis and treatment for cardiovascular diseases [3] Group 3: Industry Context and Impact - Heart disease is a leading cause of death in Canada and globally, highlighting the importance of advancements in intravascular imaging technologies [3] - The partnership with the Province of Ontario is expected to reinforce the region's position as a leader in life sciences innovation [3]